Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.27B |
| 2 |
Zimmer Biomet
ZBH
|
+$3.42B |
| 3 |
TransUnion
TRU
|
+$1.8B |
| 4 |
Qualcomm
QCOM
|
+$587M |
| 5 |
Alibaba
BABA
|
+$434M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$1.06B |
| 2 |
Pfizer
PFE
|
+$895M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$631M |
| 4 |
RTX Corp
RTX
|
+$546M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$516M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.41% |
| 2 | Healthcare | 8.04% |
| 3 | Technology | 7.66% |
| 4 | Energy | 6.94% |
| 5 | Consumer Discretionary | 6.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4326
CALL
Williams-Sonoma
WSM
$26.9B
| $1.19M | ﹤0.01% |
28,800
-5,600
| -16% | -$219K |
|
4327
Acadia Pharmaceuticals
ACAD
$4.43B
| $1.18M | ﹤0.01% |
28,286
-21,696
| -43% | -$840K |
|
4328
Elbit Systems
ESLT
$37.9B
| $1.18M | ﹤0.01% |
15,114
-13,131
| -46% | -$1.01M |
|
|
KERX
4329
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $1.18M | ﹤0.01% |
118,206
+83,068
| +236% | +$891K |
|
4330
PUT
Autohome
ATHM
$2.67B
| $1.18M | ﹤0.01% |
23,300
+1,600
| +7% | +$78.8K |
|
|
SZYM
4331
PUT
DELISTED
SOLAZYME INC COM STK (DE)
SZYM
| $1.18M | ﹤0.01% |
375,000
-601,900
| -62% | -$2.06M |
|
4332
Pan American Silver
PAAS
$18.2B
| $1.18M | ﹤0.01% |
137,037
-9,678
| -7% | -$91.1K |
|
4333
iShares Residential and Multisector Real Estate ETF
REZ
$879M
| $1.18M | ﹤0.01% |
21,017
+16,271
| +343% | +$966K |
|
|
PIR
4334
DELISTED
Pier 1 Imports, Inc.
PIR
| $1.18M | ﹤0.01% |
4,660
-7,740
| -62% | -$1.98M |
|
4335
PUT
Green Plains
GPRE
$1.18B
| $1.17M | ﹤0.01% |
42,600
+27,800
| +188% | +$856K |
|
|
ORM
4336
DELISTED
Owens Realty Mortgage, Inc.
ORM
| $1.17M | ﹤0.01% |
+78,070
| New | +$1.08M |
|
|
HOLX
4337
PUT
DELISTED
Hologic
HOLX
| $1.17M | ﹤0.01% |
30,800
+15,100
| +96% | +$529K |
|
|
SCMP
4338
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $1.17M | ﹤0.01% |
71,224
+46,985
| +194% | +$815K |
|
4339
Franklin Electric
FELE
$4.63B
| $1.17M | ﹤0.01% |
36,147
+10,005
| +38% | +$359K |
|
4340
Saia
SAIA
$9.27B
| $1.17M | ﹤0.01% |
29,755
+2,981
| +11% | +$123K |
|
|
NMBL
4341
DELISTED
Nimble Storage, Inc.
NMBL
| $1.17M | ﹤0.01% |
41,669
-62,386
| -60% | -$1.63M |
|
|
ESI
4342
DELISTED
ITT EDUCATIONAL SERVICES INC
ESI
| $1.17M | ﹤0.01% |
294,363
+219,308
| +292% | +$1.02M |
|
|
SGYP
4343
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $1.17M | ﹤0.01% |
140,714
+10,872
| +8% | +$52.7K |
|
4344
CALL
Canadian National Railway
CNI
$76.9B
| $1.17M | ﹤0.01% |
20,200
+9,200
| +84% | +$576K |
|
4345
Enpro
NPO
$6.63B
| $1.17M | ﹤0.01% |
20,396
+8,255
| +68% | +$520K |
|
|
EXAM
4346
DELISTED
EXAMWORKS GROUP INC COM STK (DE)
EXAM
| $1.17M | ﹤0.01% |
29,847
+11,022
| +59% | +$454K |
|
4347
Dr. Reddy's Laboratories
RDY
$9.87B
| $1.17M | ﹤0.01% |
105,400
-57,345
| -35% | -$633K |
|
4348
MiMedx Group
MDXG
$602M
| $1.17M | ﹤0.01% |
100,542
-10,993
| -10% | -$113K |
|
|
XIV
4349
DELISTED
VelocityShares Daily Inverse VIX Short Term ETN
XIV
| $1.17M | ﹤0.01% |
+28,697
| New | +$1.23M |
|
4350
Oxford Square Capital
OXSQ
$163M
| $1.16M | ﹤0.01% |
172,582
-24,037
| -12% | -$166K |
|
Similar funds
Goldman Sachs's Q2 2015 Portfolio in Review
As of Q2 2015, Goldman Sachs held 7,731 positions worth $323B, up 3.7% from $311B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Goldman Sachs deployed $13.1B of net new capital in Q2 2015, opening 673 new positions and adding to 3,224 existing holdings. Its largest new stake was TransUnion: 72,355,340 shares worth $1.82B.
By sector, the portfolio is most concentrated in Financials at 8.4% of assets, up from 8% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Gilead Sciences, an estimated $1.06B trimmed.
- Goldman Sachs's largest Q2 2015 buy was TransUnion: 72,355,340 shares worth $1.82B.
- Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $4.27B increase.
- Goldman Sachs's biggest Q2 2015 reduction was Gilead Sciences, cutting an estimated $1.06B.
- Goldman Sachs fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $386M.
- Goldman Sachs's ten largest holdings make up 14% of its $323B portfolio in Q2 2015.
- Goldman Sachs opened 673 new positions and closed 497 in Q2 2015.
- Goldman Sachs's portfolio value rose 3.7% quarter-over-quarter to $323B.
Based on Goldman Sachs's 13F filing for Q2 2015, filed 14 Aug 2015.